The sender is considering investing in a company developing an AI-based glucose monitoring system for diabetes management. They have conducted a tech evaluation and consulted experts but are concerned about market and regulatory challenges. They seek advice from Jeffrey E.'s network. The company, Center Health, offers a subscription model for test strips and uses AI to help manage diabetes. The memo outlines pros and cons of the investment.
documents/EFTA00715965.pdf
{}